We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ventilator Associated Tracheobronchitis in the First 14 Days in ICU

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01802827
First Posted: March 1, 2013
Last Update Posted: March 1, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Efstratios Manoulakas, University of Thessaly
  Purpose
To investigate the clinical course and risk factors for VAT and the impact of VAT on Intensive Care Unit (ICU) morbidity and mortality.

Condition
Airway Colonization Tracheobronchitis and Pneumonia Associated With Ventilator

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Efstratios Manoulakas, University of Thessaly:

Primary Outcome Measures:
  • mortality [ Time Frame: mortality at 4 weeks ]
    we assessed mortality from all causes at 4 weeks


Secondary Outcome Measures:
  • ICU length of stay [ Time Frame: expected average length of stay 15 days ]
  • mortality at 6 months [ Time Frame: 6 months ]

Biospecimen Retention:   Samples Without DNA
blood, sputum

Enrollment: 236
Study Start Date: June 2009
Study Completion Date: June 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
VAT patients
Patients developing Ventilator Associated Tracheobronchitis
VAP
Patients presenting ventilator associated pneumonia
No ventilator associated infection
patients who do not present ventilator associated infection during their stay in ICU

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
ICU patients ventilated > 48hours
Criteria

Inclusion Criteria:

  • > 48 hours mechanical ventilation

Exclusion Criteria:

  • immunodeficiency
  • pregnancy
  • severe COPD, chronic bronchitis, bronchiectasis
  • recent pneumonia
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Efstratios Manoulakas, Ph, Principal Investigator, University of Thessaly
ClinicalTrials.gov Identifier: NCT01802827     History of Changes
Other Study ID Numbers: MARKAR236
First Submitted: September 24, 2012
First Posted: March 1, 2013
Last Update Posted: March 1, 2013
Last Verified: February 2013

Keywords provided by Efstratios Manoulakas, University of Thessaly:
airway colonization
tracheobronchitis
pneumonia

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections